Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Performance of International Classification of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system.

Hougland P, Xu W, Pickard S, et al. Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system. Med Care. 2006;44(7):629-36.

Save
Print
August 9, 2006
Hougland P, Xu W, Pickard S, et al. Med Care. 2006;44(7):629-36.
View more articles from the same authors.

This Agency for Healthcare Research and Quality (AHRQ)–supported study evaluated the effectiveness of using designated ICD-9 codes to detect adverse drug events (ADEs). Investigators convened an expert panel to identify codes representing ADEs and then performed retrospective chart reviews with a structured tool to determine the success of this methodology. Overall, flagged ADE codes detected just more than half of ADEs causing hospital admission, making it a readily available tool but not a comprehensive one. Past studies have evaluated the use of ICD-9 codes for similar purposes and for surveillance of device-related hazards.

Save
Print
Cite
Citation

Hougland P, Xu W, Pickard S, et al. Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system. Med Care. 2006;44(7):629-36.

Related Resources From the Same Author(s)
Related Resources